Aim: To evaluate the protective effects of royal jelly (RJ) on the changes caused by cisplatin in paraoxonase-1 (PON-1) and arylesterase (ARE) activities. Materials and methods: Twenty-four Sprague-Dawley rats were divided into 4 groups of 6: control, royal jelly (300 mg kg-1 day-1), cisplatin (7 mg kg-1 body weight), and royal jelly (300 mg kg-1 day-1) plus a single dose of cisplatin (7 mg kg-1 body weight). Aft er the experimental procedures, blood and liver tissue samples were taken from each animal. Th e effects of RJ and cisplatin were evaluated by PON-1, ARE (in liver homogenates), and serum alanine aminotransferase measurements. Th e liver tissue was also histologically examined. Results: Administration of cisplatin reduced the PON-1 and ARE activities in the liver. However, in the rats given a pretreatment with RJ before the injection of cisplatin, the reduction caused by the cisplatin in the PON-1 and ARE activities was prevented at a signifi cant level. Th ese biochemical observations were supported by histological fi ndings and suggested that RJ restored the cisplatin-induced structural alterations in the liver tissue by the way of its antioxidant, radical scavenging, and antiapoptotic effects. Conclusion: RJ may be a potential preventive agent against the hepatic toxicity associated with cisplatin therapy. © TÜBİTAK.
CITATION STYLE
Yildirim, S., KaradenIz, A., Karakoç, A., Yildirim, A., Kalkan, Y., & ŞImşek, N. (2012). Effects of royal jelly on liver paraoxonase activity in rats treated with cisplatin. Turkish Journal of Medical Sciences, 42(3), 367–375. https://doi.org/10.3906/sag-1102-1373
Mendeley helps you to discover research relevant for your work.